New Delhi, May 22 -- Sun Pharma Q4 results 2026: Pharma major Sun Pharmaceutical Industries on Friday, 22 May, reported a 26.24% year-on-year (YoY) rise in its consolidated profit to Rs.2,714.03 crore for the January-March quarter of the financial year 2026 (Q4FY26). In the same quarter of the previous financial year, Sun Pharma's profit was Rs.2,149.88 crore.

(This is a developing story. Please check back for fresh updates.)

Published by HT Digital Content Services with permission from MINT....